Rodrigo Fernandez takes up key Astellas role to drive Latin American business

29 April 2016

Japanese drug major Astellas Pharma (TYO: 4503) has appointed Rodrigo Fernandez executive director, international business, with responsibility for managing business in Latin America outside of Brazil.

Working from Astellas' headquarters for the Americas in Northbrook, Illinois, he will report to Percival Barretto-Ko, senior vice president of international operations.

Mr Barretto-Ko said: "With a population of more than 600 million people facing numerous unmet clinical needs, Latin America is a critical area for Astellas. Rodrigo's deep experience in this region, approach to collaboration and impressive track record in commercial operations will serve Astellas well as we seek to turn innovative science into value for patients."

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK